Clinical trial

Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA

NCT04698330

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Berberine Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Inulin Normalized identity: inulinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Berberine placebo tablets Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Inulin placebo tablets Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2022-05-01

PhasePHASE4

Conditions

Type 1 Diabetes Mellitusverified · MONDO: type 1 diabetes mellitus

Autoimmune Diabetesunresolved

Interventions

BerberineDRUG

InulinDRUG · verified · RxNorm: inulin

Berberine placebo tabletsDRUG

Inulin placebo tabletsDRUG

Sponsors & collaborators

Second Xiangya Hospital of Central South Universitylead sponsor

Mapped research locations

ChangshaHunan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04698330 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.